SNGX: Soligenix Inc Company Short-Term Debt

Symbol and logo of brand Soligenix, Inc. (SNGX)

The short-term borrowing metric clearly demonstrates the debt load of Soligenix, Inc. (SNGX), with the value 0.00 reflecting the current amount of liabilities. Soligenix, Inc. (SNGX) is recruiting leading toxicologists to develop anti-infective agents under strict scientific regulations. Geopolitical tensions are driving government orders for biodefense, while a focus on defense contracts and specialized centers ensures the stability of this niche business.

SNGX (soligenix.com) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Metric breakdowns and analytics for Soligenix Inc (SNGX)

- current quotes and average value forecast:
Price Chart BioPharma Bio|SNGX - Fair Value Consensus
- market capitalization information:
Market Value Soligenix, Inc.|SNGX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Soligenix|SNGX - Book Capitalization|Market Cap to Net Assets Ratio soligenix.com|SNGX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Soligenix, Inc.|SNGX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity BioPharma Bio|SNGX - Company Aggregate Debt|Debts to Book Capitalization Soligenix, Inc.|SNGX - Long-Term Liabilities|Company Short-Term Debts Soligenix|Quick Ratio soligenix.com
- net income and valuation multiples indicators:
SNGX - Net Income
Fundamental valuation:soligenix.com (SNGX)
Manufactured products of BioPharma Bio

Facing fierce competition from pharmaceutical behemoths in the development of orphan drugs, Soligenix, Inc. requires strict control over its operating capital. This metric aggregates all liabilities maturing within twelve months, allowing investors to assess the risk of cash flow gaps and liquidity stability, which is clearly reflected in the trend of short-term credit obligations.

Key competitors

SMMT - Company Short-Term Debt|Company Short-Term Loans and Borrowings MRNA (Moderna Inc)|Vaxcyte Corp (PCVX) - Company Short-Term Debt|Company Current Liabilities Tarsus Corp|CRMD (CorMedix Inc.) - Company Short-Term Debts|Company Short-Term Debts serestherapeutics.com|Company Current Liabilities SPRO (Spero Therapeutics, Inc.)|SCYX (scynexis.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ANTX (AN2 Therapeutics)|Short-Term Debt Volume PolyPid Ltd (PYPD)|LSB - Company Short-Term Debt|ITRM (Iterum Therapeutics plc) - Company Short-Term Indebtedness|PHGE: Company Short-Term Debts|Current Liabilities SXTP (60 Degrees Pharmaceuticals, Inc.)|OGEN (Oragenics, Inc.) - Company Short-Term Debts|Short-Term Debt Onconetix Corporation ONCO|Company Short-Term Debts OPGN